Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.
A Phase 3, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Male Participants With Androgenetic Alopecia.
In the register
The register attaches this trial to Minoxidil (topical), currently at “Approved” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Not yet recruiting
- Declared phase
- Phase 3
- Sponsor
- Eurofarma Laboratorios S.A.
- Participants (registry)
- 372
- Start
- January 2027 (planned)
- Primary completion
- October 2028 (planned)
- Study completion
- October 2028 (planned)
- Last registry update
- April 2026
- Countries
- —
Conditions studied: Androgenetic Alopecia, Androgenetic Alopecia (AGA)
Interventions: Minoxidil oral solution, Placebo oral solution
Other trials of Minoxidil (topical)
Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia
Efficacy & Safety of Minoxidil SL Tablets in Men With AGA
- NCT07056933Not yet recruiting
Effect of Minoxidil Solution Iontophoresis on Androgenic Alopecia
Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia
Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia
Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia
Treatment of Androgenetic Alopecia in Men for 24 Weeks
Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia
- NCT02486848Withdrawn
Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil
Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.